Physicians for Reproductive Health: Homepage
Donate
  • Training
    • Leadership Training Academy
    • Meet Our Advocates
    • LTA Hub Login
  • Resources
    • Resource Hub
  • Policy Work
    • PRH in Action
  • News
    • Press Releases
    • Blog
    • Press Mentions
    • Resources for Journalists
  • About Us
    • Mission and Vision
    • Our Impact
    • Financials
    • Our People
    • Careers
  • Support
    • Donate
    • Voices of Courage
    • Join Our Network
    • Purchase Merch
Donate

Tagged: FDA

Press Release
January 3, 2023

FDA Affirms Mifepristone is Safe and Should Be Accessible

Today the FDA updated its guidance on mifepristone to no longer require in-person dispensing. President and CEO of Physicians for Reproductive Health Dr. Jamila Perritt, […]

  • FDA (3)
  • medication abortion (26)
  • mifepristone (4)
  • press release (295)
Press Release
April 13, 2021

FDA Lifts Restrictions on Medication Abortion

Late last night, the Food and Drug Administration shared by way of a letter to advocates at the American College of Obstetricians and Gynecologists that […]

  • abortion (499)
  • FDA (3)
  • medication abortion (26)
Update
March 10, 2021

Medication Abortion – It’s Time to Act!

Welcome back to our blog series, PRH in Action! This month we’re diving into the unnecessary regulation of medication abortion care and what the Biden Administration must do now to ensure access.  Medication abortion is […]

  • Biden (6)
  • FDA (3)
  • medication abortion (26)
  • mifepristone (4)
  • PRH in Action (75)

Sitemap

  • Newsroom
  • Careers
  • Privacy Policy
  • Contact Us
  • Accessibility

Join us

We deliver breaking news and ways to take action straight to your inbox.

Subscribe

Social Media

  • Facebook
  • Instagram
  • Bluesky